Literature DB >> 19442903

Percutaneous thermal ablation in the head and neck: current role and future applications.

Gerald Wyse1, H Hong, Kieran Murphy.   

Abstract

Patients with recurrent head and neck cancer have poor quality of life and suffer dismally from debilitating symptoms. Ablative techniques offer patients an alternative, minimally invasive treatment option. As a palliative treatment, they improve quality of life with decreased pain, improved function and appearance. In addition, there is a reduction in tumor bulk and analgesia requirements. Advantages include a reduction in procedural cost, avoidance of complex repetitive surgeries, and an ability to visualize the treated area at the time of the procedure. Ablation therapies are an evolving and exciting treatment option in the head and neck, but a consensus on appropriate indications is currently unclear.

Entities:  

Mesh:

Year:  2009        PMID: 19442903     DOI: 10.1016/j.nic.2009.01.004

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  3 in total

1.  Magnetic nanoparticle-based hyperthermia for head & neck cancer in mouse models.

Authors:  Qun Zhao; Luning Wang; Rui Cheng; Leidong Mao; Robert D Arnold; Elizabeth W Howerth; Zhuo G Chen; Simon Platt
Journal:  Theranostics       Date:  2012-01-15       Impact factor: 11.556

Review 2.  The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer.

Authors:  Ranjeeta Thapa; George D Wilson
Journal:  Stem Cells Int       Date:  2016-04-21       Impact factor: 5.443

3.  Efficacy and Safety of Thermal Ablation for Treating Lymph Node Metastasis From Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Zheng Ding; Juan Chen; Zhiguang Chen; Xiaoke Zeng; Pengchao Zheng; Xuemei Wang; Xinwu Cui; Liang Sang
Journal:  Front Oncol       Date:  2022-04-01       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.